The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Presence of myeloid-derived suppressor cells (MDSC) in patients with metastatic castration-sensitive and castration-resistant prostate cancer.
 
Karen A. Autio
No Relationships to Disclose
 
Phillip Wong
No Relationships to Disclose
 
Angel Rabinowitz
No Relationships to Disclose
 
Jianda Yuan
No Relationships to Disclose
 
Lauryn Michelle Slavin
No Relationships to Disclose
 
Ryan Brennan
No Relationships to Disclose
 
Melineh DerSarkissian
No Relationships to Disclose
 
Zhenyu Mu
No Relationships to Disclose
 
Howard I. Scher
Honoraria - Chugai Pharma
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Endo Pharmaceuticals; Endocyte; Exelixis; Ferring; Foundation Medicine; Genentech; Janssen; OncologySTAT; Palmetto GBA; Pfizer; Sanofi; Takeda; Ventana Medical Systems; WIRB-Copernicus Group
Speakers' Bureau - WebMD
Research Funding - BIND Biosciences (Inst); Epic Sciences (Inst); Exelixis (Inst); Guardant Health (Inst); Janssen (Inst); Janssen Diagnostics (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Endocyte; Exelixis; Ferring; Genentech; Janssen; Pfizer; Sanofi; Takeda; WIRB-Copernicus Group
 
Alexander M. Lesokhin
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center